Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), the antibiotic Zithromax (azithromycin), Viagra (sildenafil) for erectile dysfunction, and the anti-inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside the USA and Canada, mainly in South America). Its headquarters are in Midtown Manhattan, New York City.
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
Latest FEC Datacovers through committee's March 29, 2010 filing.
Summaryoverview of the committee's finances
- Total Raised:
- Total Spent:
- Cash on Hand:
Standardized Donation Informationfederal data covers roughly through Q2 2014
state-level data is not available in bulk for 2014. for current state data, browse http://followthemoney.org/
- PAC Color Block
- Organization's PAC(s)
- Employee Color Block
- Associated Individuals
Republicans vs. Democratsin dollars. "Other" includes 3rd parties and organizations without official party affiliation.
State vs. Federalin dollars
Top PAC Recipients
- PAC Color Block
- Organization's PAC(s)
- Employee Color Block
- Associated Individuals
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Pfizer Inc
Names of Lobbyists
Firm Hired Amount Pfizer Inc $36,460,000 Wyeth $2,459,268
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Copyright, Patent & Trademark,
- Fed Budget & Appropriations,
- Consumer Product Safety,
- Labor, Antitrust & Workplace
Most Frequently Disclosed Bills
Bill No. Title H.R.1548 Pathway for Biosimilars Act H.R.1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R.3200 America's Affordable Health Choices Act of 2009 S.301 Physician Payments Sunshine Act of 2009 H.R.1 American Recovery and Reinvestment Act of 2009 H.R.3590 Service Members Home Ownership Tax Act of 2009 S.726 Promoting Innovation and Access to Life-Saving Medicine Act S.501 Fair Prescription Drug Competition Act H.R.684 Medicare Prescription Drug Savings and Choice Act of 2009 H.R.4213 Tax Extenders Act of 2009
RegulationsMentioned in 301 dockets; Submitted to 48 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Pfizer Inc" in public comments on proposed federal regulations.
Documents Submitted by the Organization
View all submissions data for Pfizer Inc
- Toggle 2 FDA Good Laboratory Practice for Nonclinical Laboratory Studies 2010
- Toggle 2 FDA Patent Term Extension Application for CONVENIA® (Cefovecin Sodium), U.S. Patent No. 6,020,329 2009
- Toggle 1 FDA Participation of Certain Population Subsets in Clinical Drug Trials; Request for Comment 2009
- Toggle 1 FDA Veterinary Feed Directive 2010
- Toggle 1 FDA Investigational New Drug Applications; Co-Development of Investigational Drugs 2010
- Toggle 1 FDA Draft Guidance for Industry on Non-Inferiority Clinical Trials; Availability 2010
- Toggle 1 FDA Draft Guidance for Industry on Good Importer Practices; Availability 2009
- Toggle 1 FDA Draft Guidance for Industry on Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Developing Drugs for Treatment; Availability 2010
- Toggle 1 FDA Draft Guidance for Industry on Assay Development for Immunogenicity Testing of Therapeutic Proteins; Availability 2009
- Toggle 1 FDA International Conference on Harmonisation; Draft Guidance on Addendum to ICH S6; Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals S6(R1); Availability 2009
Mentions in Document Text
View all mentions data for Pfizer Inc
- Toggle 22 FDA NADA/ANADA Notices 2010
- Toggle 17 FDA NADA/ANADA Notices 2009
- Toggle 16 EPA Rulemaking for the Steam Electric Power Generating Effluent Limitations Guidelines 2009
- Toggle 14 USTR 2010 Special 301 2010
- Toggle 13 EPA Clean Air Transport Rule 2009
- Toggle 11 USCIS Allowing Certain H-4 Dependent Spouses to Apply for Employment Authorization 2010
- Toggle 10 FDA Patent Term Extension Application for CONVENIA® (Cefovecin Sodium), U.S. Patent No. 6,020,329 2009
- Toggle 9 FDA Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools; Notice of Public Hearing 2009
- Toggle 8 EPA Approval and Promulgation of Air Quality Implementation Plans; Connecticut; Approval of NOx Emission Trading Orders as Single Source SIP Revisions 2010
- Toggle 7 CMS Medicaid Prescription Drugs Average Manufacture Price 2010
Contractor Misconduct4 Instances
This information is collected by the Project On Government Oversight from press releases, court documents, news reports and other public records. It is not meant to be an exhaustive account of all instances of federal contractor misconduct.
More information on each instance, including primary source documents, is available on POGO's site by clicking on the instance description. More information on POGO's methodology is available here.
|Misconduct Type||Hired By||Incident||Year||Disposition||Penalty|
|Health||None||Illegal Marketing of Bextra and Other Drugs||2009||Pleaded Guilty||$2,300,000,000|
|Health||None||Illegal Testing in Nigeria||2009||Settlement||$75,000,000|
|Antitrust||None||Hawaii Average Wholesale Price Litigation||2010||Settlement||$8,200,000|
|Health||None||FDA Inspection of New York City Facility||2010||Investigative Finding||$0|
EPA Violations1 Enforcement Actions
Figures are based on data from the Environmental Protection Agency’s ECHO website. The ECHO database contains federal and state environmental enforcement actions. Data displayed here includes only those actions that began after 2000 and resulted in fines of over $1 million.
Actions where the company was the sole defendant are listed first. Actions where the company is one of multiple defendants are listed subsequently.
For more information see our EPA methodology page.
|Old Southington Landfill||Pharmacia Corporation (+85 others)||2009||Southington, Ct||$4,248,450|
Advisory Committees19 people on 14 committees
Data is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.
The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.
Table shows employees of "Pfizer Inc" that sat on federal advisory committees.
- Toggle Department of Health and Human Services 13 people on 9 committees
- Toggle Department of Commerce 2 people on 2 committees
- Toggle Department of State 2 people on 1 committee
- Toggle Department of Defense 1 person on 1 committee
- Toggle National Science Foundation 1 person on 1 committee